QR Code

Citicoline Triggers Proteome Remodeling and Proteostatic Adaptation: Evidence from Shotgun Proteomics

<b>Background/Objectives</b>: Citicoline, also known as CDP-choline, is a nootropic agent currently used in the treatment of glaucoma and is undergoing evaluation as a first-line therapy in a multi-center, international, phase III, randomized clinical trial involving citicoline eyedrops (ClinicalTri...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Dario Cavaterra, Sara Giammaria, Irene Pandino, Gabriele Antonio Zingale, Valerio Delli Paoli, Rebecca Fiore, Manuele Michelessi, Gloria Roberti, Carmela Carnevale, Lucia Tanga, Daniela Cazzato, Elisa Peroni, Giuseppe Grasso, Gianluca Manni, Alessio Bocedi, Francesco Oddone, Massimiliano Coletta, Diego Sbardella, Grazia Raffaella Tundo
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2026-01-01
Rangatū:Pharmaceutics
Ngā marau:
citicoline
glaucoma
proteomics
proteostasis
proteasome
Urunga tuihono:https://www.mdpi.com/1999-4923/18/1/61
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite